Trial to Optimally Show the Pharmacological Action of Z-100

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

July 20, 2021

Study Completion Date

December 10, 2021

Conditions
Cervical Cancer
Interventions
DRUG

Z-100

Twice a week until 29 days after completion of chemoradiotherapy, then once every 14 days

DRUG

Placebos

Twice a week until 29 days after completion of chemoradiotherapy, then once every 14 days

Trial Locations (2)

Unknown

Zeria Investrigative Sites, Hanoi

Zeria Investigative sites, Ho Chi Minh City

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY